| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/31/2004 | EP1402062A1 Bioinformatics based system for assessing a condition of a performance animal by analysing nucleic acid expression |
| 03/31/2004 | EP1402060A2 Use of semaphorin 3a for diagnosing and treating cancer, especially prostate cancer |
| 03/31/2004 | EP1402058A2 Dgks as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1402057A2 Method for detecting mutagenic substances |
| 03/31/2004 | EP1402056A2 Noninvasive intraductal fluid diagnostic screen |
| 03/31/2004 | EP1402054A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 03/31/2004 | EP1402053A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 03/31/2004 | EP1402052A2 Automated method for correcting blood analysis parameter results affected by interference from exogenous blood substitutes in whole blood, plasma, and serum |
| 03/31/2004 | EP1402051A2 Lces as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1402040A2 A novel intein and uses thereof |
| 03/31/2004 | EP1402035A2 G-protein coupled receptors and dna sequences thereof |
| 03/31/2004 | EP1402034A2 Identification of ses-1 and the uses of the same |
| 03/31/2004 | EP1402032A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis |
| 03/31/2004 | EP1402031A2 Atopy |
| 03/31/2004 | EP1402025A1 Chimaeric phages |
| 03/31/2004 | EP1402024A2 Templated molecules and methods for using such molecules |
| 03/31/2004 | EP1402021A1 A gene and uses therefor |
| 03/31/2004 | EP1402015A2 A soluble complex comprising a retroviral surface glycoprotein |
| 03/31/2004 | EP1402009A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof |
| 03/31/2004 | EP1402000A2 Structural and cytoskeleton-associated proteins |
| 03/31/2004 | EP1401999A2 B7 related protein-2 molecules and uses thereof |
| 03/31/2004 | EP1401918A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/31/2004 | EP1401870A2 Antibodies against tumor necrosis factor delta (april) |
| 03/31/2004 | EP1401869A1 Molecules and methods for inhibiting shedding of kim-1 |
| 03/31/2004 | EP1401867A2 Mycobacterial antigens expressed under low oxygen tension |
| 03/31/2004 | EP1401865A2 Pathogenic and commensal vaccine antigens |
| 03/31/2004 | EP1401861A2 Cads as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1401855A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 03/31/2004 | EP1401853A1 Modulators of pharmacological agents |
| 03/31/2004 | EP1401801A1 Selective androgen receptor modulators and methods of use thereof |
| 03/31/2004 | EP1401490A1 Tsg101 as inhibitor of hiv production |
| 03/31/2004 | EP1401482A1 Yin yang-1 |
| 03/31/2004 | EP1401476A2 Igf antagonist peptides |
| 03/31/2004 | EP1401475A2 Prmts as modifiers of the p53 pathway and methods of use |
| 03/31/2004 | EP1401472A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 03/31/2004 | EP1401470A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 03/31/2004 | EP1401469A2 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways |
| 03/31/2004 | EP1401456A1 Method fron determining the efficacy of reverse cholesterol transport enhancing agents |
| 03/31/2004 | EP1401416A2 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd) |
| 03/31/2004 | EP1401415A2 Use of tyrosine kinase inhibitors for treating inflammatory diseases |
| 03/31/2004 | EP1401412A2 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis |
| 03/31/2004 | EP1401411A2 Use of tyrosine kinase inhibitors for treating bone loss |
| 03/31/2004 | EP1401410A2 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 03/31/2004 | EP1401401A2 Method for high through put screening using a small scale mill or microfluidics |
| 03/31/2004 | EP1401334A1 A urine collection device |
| 03/31/2004 | EP1401322A2 Method and system for optically performing an assay to determine a medical condition |
| 03/31/2004 | EP1401281A2 Toll/interleukin-1 receptor adaptor protein (tirap) |
| 03/31/2004 | EP1401269A2 Transgenic animal model of bone mass modulation |
| 03/31/2004 | EP1390523A4 Methods and devices for the quantitative detection of prostate specific membrane antigen and other prostatic markers |
| 03/31/2004 | EP1373874A4 Method and apparatus for the confinement of materials in a micromachined chemical sensor array |
| 03/31/2004 | EP1366059A4 Methods and compositions for modulating gluconeogenesis using pgc-1 |
| 03/31/2004 | EP1255851A4 Methods of diagnosing and monitoring endometrial glandular development |
| 03/31/2004 | EP1222468B1 Multiplex cytokine analysis |
| 03/31/2004 | EP1218722B1 Quantitative detection of viruses by light scattering |
| 03/31/2004 | EP1208387B1 Apparatus and method of detecting and controlling twists in multicore cables |
| 03/31/2004 | EP1190241A4 Microfluidic devices for transverse electrophoresis and isoelectric focusing |
| 03/31/2004 | EP1173710B1 Device for adjusting the oxidation agent/fuel mixture in the feeding pipe of a burner |
| 03/31/2004 | EP1169476A4 Detection of melanoma |
| 03/31/2004 | EP1110073B1 Apparatus for and method of collecting gaseous mercury and differentiating between different mercury components |
| 03/31/2004 | EP1083948B1 Method for determining waste products in the dialysis liquid in dialysis treatment |
| 03/31/2004 | EP1058849B1 Environmental biosensor for measuring air contaminants |
| 03/31/2004 | EP1019507B1 Amino-terminally truncated rantes as chemokine antagonists |
| 03/31/2004 | EP1019453B1 Aromatic-substituted xanthene dyes |
| 03/31/2004 | EP1003863B1 Mammalian cytokine receptor-11 |
| 03/31/2004 | EP0944828B1 Therapeutic agent with quantitative consumption marker and method of monitoring therapeutic agent consumption |
| 03/31/2004 | EP0927331B1 Macroscopically manipulable nanoscale devices made from nanotube assemblies |
| 03/31/2004 | EP0866860B1 Novel tyrosine kinase receptors and ligands |
| 03/31/2004 | EP0852011B1 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc |
| 03/31/2004 | EP0731806B1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
| 03/31/2004 | EP0710253B1 Antibodies specific for human prostate glandular kallikrein |
| 03/31/2004 | CN2608987Y Biochip pointing sample device |
| 03/31/2004 | CN2608986Y Double fan shaped miller sight disk |
| 03/31/2004 | CN2608985Y Rotor less vulanization apparatus, mould body |
| 03/31/2004 | CN2607950Y Carbon dioxide absorber with filter |
| 03/31/2004 | CN1486426A Methods for measuring stress in mammals |
| 03/31/2004 | CN1486425A Multiple target test useful for pre-donation screening of blood |
| 03/31/2004 | CN1486423A Quantitative analyzing method and quantitative analyzer using sensor |
| 03/31/2004 | CN1486420A Apparatus and method for monitoring characteristics of pharmaceutical compositions during preparation in a fluidized bed |
| 03/31/2004 | CN1486395A Determining the viscosity of a hydrocarbon reservoir fluid |
| 03/31/2004 | CN1486394A Measuring the in situ static formation temperature |
| 03/31/2004 | CN1486328A Method for surface display of proteins on genetic carriers |
| 03/31/2004 | CN1486320A Inhibitors of cruzipain and other cysteine proteases |
| 03/31/2004 | CN1486190A Compositions containing an active fraction isolated from scutellariae barbatae and methods of use |
| 03/31/2004 | CN1485619A Allergen (sensitinogen) protein chip detecting process |
| 03/31/2004 | CN1485618A Test piece |
| 03/31/2004 | CN1485617A An optical circulation amplification type biological chip detecting process |
| 03/31/2004 | CN1485616A Fowl eggs quality non-destruction automatic detection grading apparatus and process |
| 03/31/2004 | CN1485613A Reflector and reflective liquid crystal display device provided with the reflector |
| 03/31/2004 | CN1485603A Liquid column impact type liquid coating method |
| 03/31/2004 | CN1485342A Method for preparing specific Immunoglobulin of cystvirus and adenovirus in respiratory tract |
| 03/31/2004 | CN1144050C Ration method of cholesterol in high-density lipoprotein |
| 03/31/2004 | CN1144049C Noninvasive transdermal systems for detecting analytes |
| 03/31/2004 | CN1144048C Process for detecting analytes by measurement of residual magnetism and compound |
| 03/31/2004 | CN1144047C Method for testing or determining HCV core antigen and the agent for same |
| 03/31/2004 | CN1144046C Device for enzymoimmunodiacolation detection and its production method |
| 03/31/2004 | CN1144045C Method for identifying and quantifying polymers utilizing immunoassay techniques |
| 03/31/2004 | CN1144044C Method and apparatus for testing filtration efficiency of cloth material intended for use in clean room environment |
| 03/31/2004 | CN1144043C Measurement device for determining properties of liquid |
| 03/31/2004 | CN1144040C CO sensor and its producing method |
| 03/31/2004 | CN1144036C Device for measuring the stickiness of a flowable medium |